Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 study
在健康印尼成年人中评估佐以明矾+CpG 1018的SARS-CoV-2重组蛋白亚单位疫苗的安全性和免疫原性：一项多中心、随机、对照、观察者盲法、安慰剂对照的II期研究
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2024.2429231
Maddeppungeng, Martira; Nurdin, Asrawati; Nency, Yetty Movieta; Sekartini, Rini; Medise, Bernie Endyarni; Soedjatmiko, Soedjatmiko; Massi, Muh Nasrum; Darma, Sidrah; Darussalam, Andi Husni Esa; Ramadhani, Nur; Hidayah, Najdah; Chalid, Maisuri Tadjuddin; Ramadany, Sri; Wahyuni, Sitti; Djaharuddin, Irawaty; Santoso, Arif; Fikri, Bahrul; Alimuddin, Suriani; Pelupessy, Ninny Meutia; Masadah, Rina; Putri, Azka Zhafira; Setyaningsih, Lilis; Yani, Finny Fitry; Anggrainy, Fenty; Deza, Putri Awaliyah; Maharani, Nani; Mahati, Endang; Hapsari, Rebriarina; Farhanah, Nur; Pramudo, Setyo Gundi; Tri Anantyo, Dimas
